Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$165.21M

FY 2025 · Annual

+15.0% YoY

Investing Cash Flow

-$119.02M

FY 2025 · Annual

Financing Cash Flow

$180.43M

FY 2025 · Annual

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income11.5M69.55M33.98M75.21M96.66M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
Deferred Income Tax6.61M(46K)4.01M23.86M(7.87M)
Stock-Based Compensation3.7M2.64M4.2M1.89M696K
Change in Working Capital9.29M54.06M(41.2M)22.85M57.02M
Accounts Receivables(13.77M)4.04M(29.2M)(3.58M)18.56M
Inventory(11.1M)0000
Accounts Payables11.1M48.62M(14.43M)31.92M25.24M
Other Working Capital23.05M1.4M2.43M(5.48M)13.22M
Other Non-Cash Items(10.59M)(59.46M)(9.94M)(13.51M)(18.54M)
Operating Cash Flow59.08M98.87M23.28M143.64M165.21M
Capital Expenditures(65.18M)(101.63M)(129.41M)(41.95M)(101.81M)
Acquisitions (Net)0253.14M00(75.12M)
Purchases of Investments0000(1.08M)
Sales of Investments00029.47M57.36M
Other Investing Activities5.79M4.13M44.96M3.37M1.63M
Investing Cash Flow(59.39M)155.64M(84.45M)(9.11M)(119.02M)
Debt Repayment(29.98M)(114.23M)18.67M(44.53M)30.61M
Common Stock Issued0000191.52M
Common Stock Repurchased0(35.02M)(11.06M)00
Dividends Paid(42.99M)(42.55M)(40.43M)(40.02M)(41.7M)
Other Financing Activities(1.86M)(56K)1.89M(3.31M)0
Financing Cash Flow(74.84M)(191.86M)(30.93M)(87.87M)180.43M
Effect of Forex Changes(184K)155K000
Net Change in Cash(75.33M)62.65M(92.1M)46.66M226.63M
Free Cash Flow(6.1M)(2.76M)(106.13M)101.69M63.4M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$96.7M
+ D&A$37.2M
+ Stock-Based Comp$696.0K
- Deferred Tax-$7.9M
+ Working Capital$57.0M
- Other Non-Cash-$18.5M
= Operating Cash Flow$165.2M
- Capex-$101.8M
= Free Cash Flow$63.4M

Analysis

FY2025 free cash flow is $63.4M. FCF conversion is 65.6% of net income. Operating cash flow was $165.2M, with capex of -$101.8M. The largest bridge item is Capex at -$101.8M.

Recent Filings

Recent regulatory filings

No filings found.

Does EXE.TO generate free cash flow?

Extendicare Inc. (EXE.TO) generated $63.40M of free cash flow in fiscal 2025.

How much operating cash flow does EXE.TO produce?

Operating cash flow was $165.21M, before capital expenditures of $101.81M.